Lipoprotein-associated phospholipase A2 – a new position in the risk stratification?

Authors

  • D. Nozadze FSU Russian Cardiological Research and Production Complex of the Ministry of Health and the SR of the Russian Federation
  • A. Semenova FSU Russian Cardiological Research and Production Complex of the Ministry of Health and the SR of the Russian Federation
  • V. Kaminnaya FSU Russian Cardiological Research and Production Complex of the Ministry of Health and the SR of the Russian Federation
  • T. Vlasik FSU Russian Cardiological Research and Production Complex of the Ministry of Health and the SR of the Russian Federation
  • I. Sergienko FSU Russian Cardiological Research and Production Complex of the Ministry of Health and the SR of the Russian Federation

Keywords:

Lipoprotein-associated phospholipase A2, risk stratification, unstable atherosclerotic plaque

Abstract

Authors consider possibility of using lipoprotein-associated phospholipase A2 (Lp-PLA2) for the assessment of
atherosclerotic plaque’s status and for its risk stratification application. Mechanisms of Lp-PLA2 secretion regulation
and Lp-PLA2 impact on the atherosclerotic plaque destabilization are described

Downloads

Download data is not yet available.

Downloads

Published

2011-03-30

How to Cite

Nozadze D., Semenova A., Kaminnaya V., Vlasik T., Sergienko I. Lipoprotein-associated phospholipase A2 – a new position in the risk stratification? // The Journal of Atherosclerosis and Dyslipidemias. 2011. VOL. № 1 (2). PP. 41–47.

Issue

No. 1 (2) (2011)

Section

Key Article